Enabling a £9m Healthcare Acquisition to Support International Growth

A fast growing healthcare business instructed Taylor Rose on the £9 million acquisition of a specialist healthcare product manufacturer. The transaction completed smoothly, strengthening the client’s international footprint and enabling them to progress confidently with further growth and restructuring plans.

What happened, and what was the outcome?

Taylor Rose advised on the £9 million acquisition of a specialist healthcare product manufacturer as part of the client’s wider expansion strategy. The deal completed efficiently and gave the client access to new EU markets alongside an established network of overseas manufacturers, supporting long term commercial growth.

What was the situation, and why did it matter?

The client was actively pursuing acquisitions to build scale, resilience and operational flexibility within a competitive healthcare market. This transaction played a key role in that strategy. The target company was highly attractive and had multiple interested bidders, making speed, clarity and certainty essential to securing the deal.

It offered several important commercial advantages:

• Expansion into other EU jurisdictions

• Access to an established manufacturing network across multiple foreign jurisdictions, including China

• Improved supply chain resilience and cost control

Timing was critical. The client wanted to maintain momentum across its wider acquisition and restructuring programme. Delays or unmanaged risks could have slowed decision making and disrupted future opportunities.

How did expertise make the difference?

Cross border healthcare acquisitions can introduce a wide range of legal and commercial risks. The challenge was not simply identifying those risks, but ensuring the client understood which issues genuinely mattered to the value and future operation of the business.

The transaction involved:

• Multiple jurisdictions with different legal and regulatory frameworks

• Overseas manufacturing arrangements that required commercial, not purely legal, assessment

• Tight timeframes that demanded clear and decisive advice

The client needed practical guidance that translated complexity into straightforward choices, allowing leadership to remain focused on strategic growth.

What did we actually do?

Taylor Rose supported the client throughout the transaction, from initial due diligence through to completion.

Our work included:

• Managing a targeted due diligence process focused on material commercial risk

• Coordinating with lawyers in relevant foreign jurisdictions to ensure consistent and aligned advice

• Advising on pragmatic risk mitigation solutions that avoided unnecessary delay

• Keeping the transaction on schedule by coordinating advisers and maintaining deal momentum

Advice was delivered in clear, accessible language so the client could make informed decisions quickly and with confidence.

What difference did it make?

The acquisition completed without delay and delivered immediate commercial value.

As a result, the client:

• Expanded its presence into additional EU markets

• Secured access to a reliable international manufacturing network

• Strengthened supply chain resilience and operational efficiency

• Remained well positioned to pursue further restructuring and acquisition opportunities

The transaction supported the client’s long term strategy rather than distracting from it.

Conclusion

This case study demonstrates Taylor Rose’s commercially focused approach to corporate acquisitions. We help clients navigate complex transactions with clarity and confidence, ensuring legal advice actively supports business growth.

Taylor Rose advises businesses on acquisitions, disposals and restructuring, providing clear and pragmatic solutions that deliver real commercial impact.